| Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion PE Verweij, BJA Rijnders, RJM Brüggemann, E Azoulay, M Bassetti, ... Intensive care medicine 46 (8), 1524-1535, 2020 | 362 | 2020 |
| Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study … Z Karami, BT Knoop, ASM Dofferhoff, MJT Blaauw, NA Janssen, ... Infectious Diseases 53 (2), 102-110, 2021 | 168 | 2021 |
| Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study EJ Kooistra, NJB Waalders, I Grondman, NAF Janssen, AH de Nooijer, ... Critical Care 24 (1), 1-12, 2020 | 129 | 2020 |
| Increased plasma heparanase activity in COVID-19 patients B Buijsers, C Yanginlar, A de Nooijer, I Grondman, ML Maciej-Hulme, ... Frontiers in immunology 11, 2572, 2020 | 129 | 2020 |
| Multinational observational cohort study of COVID-19–associated pulmonary Aspergillosis NAF Janssen, R Nyga, L Vanderbeke, C Jacobs, M Ergün, JB Buil, ... Emerging infectious diseases 27 (11), 2892, 2021 | 111 | 2021 |
| Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes AH de Nooijer, I Grondman, NAF Janssen, MG Netea, L Willems, ... The Journal of infectious diseases 223 (2), 214-224, 2021 | 111 | 2021 |
| Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial L Vanderbeke, NAF Janssen, DCJJ Bergmans, M Bourgeois, JB Buil, ... Intensive care medicine, 1-13, 2021 | 76 | 2021 |
| Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19 NAF Janssen, I Grondman, AH de Nooijer, CK Boahen, VACM Koeken, ... The Journal of Infectious Diseases 223 (8), 1322-1333, 2021 | 76 | 2021 |
| Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19 LH Willems, M Nagy, H Ten Cate, HMH Spronk, LA Groh, J Leentjens, ... Thrombosis Research 209, 106-114, 2022 | 74 | 2022 |
| Aspergillus test profiles and mortality in critically ill COVID-19 patients M Ergün, RJM Brüggemann, A Alanio, S Dellière, A van Arkel, ... Journal of clinical microbiology 59 (12), e01229-21, 2021 | 64 | 2021 |
| Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study N Pouw, J van de Maat, K Veerman, J Ten Oever, N Janssen, E Abbink, ... PloS one 16 (3), e0248713, 2021 | 64 | 2021 |
| A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients EJ Kooistra, AH de Nooijer, WJ Claassen, I Grondman, NAF Janssen, ... International Journal of Obesity 45 (3), 687-694, 2021 | 56 | 2021 |
| Invasive pulmonary aspergillosis associated with viral pneumonitis IMW Dewi, NAF Janssen, D Rosati, M Bruno, MG Netea, ... Current Opinion in Microbiology 62, 21-27, 2021 | 51 | 2021 |
| Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis G Nijman, M Wientjes, J Ramjith, N Janssen, J Hoogerwerf, E Abbink, ... PloS one 16 (3), e0249231, 2021 | 32 | 2021 |
| Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 AH de Nooijer, I Grondman, S Lambden, EJ Kooistra, NAF Janssen, ... Bioscience Reports, 2021 | 28 | 2021 |
| The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19 I Grondman, AH de Nooijer, N Antonakos, NAF Janssen, M Mouktaroudi, ... The Journal of Clinical Endocrinology & Metabolism 106 (7), 1994-2009, 2021 | 23 | 2021 |
| Prior use of therapeutic anticoagulation does not protect against COVID‐19 related clinical outcomes in hospitalized patients: a propensity score‐matched cohort study JP Spiegelenberg, MMHJ van Gelder, ML Maas, MMC Hovens, ... British Journal of Clinical Pharmacology, 2021 | 22 | 2021 |
| A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection FL van de Veerdonk, NAF Janssen, I Grondman, AH de Nooijer, ... medRxiv, 2020 | 19 | 2020 |
| Joosten LAB, Nijenhuis T, Netea MG, Hilbrands L, van de Veerdonk FL, Duivenvoorden R, de Mast Q and van der Vlag J (2020) Increased Plasma Heparanase Activity in COVID-19 Patients B Buijsers, C Yanginlar, A de Nooijer, I Grondman, ML Maciej-Hulme, ... Front. Immunol. 11: 575047. doi: 10.3389, 2020 | 14 | 2020 |
| A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology NAF Janssen, RJM Brüggemann, MH Reijers, SSV Henriet, J Ten Oever, ... Journal of Fungi 6 (4), 274, 2020 | 12 | 2020 |